Dysregulated alveolar type 2 epithelial cell proteostasis promotes fibrogenic macrophage migration inhibitory factor–CD74 signaling
Science Translational Medicine · 03.12.2025 · 17 (827)
DOI: 10.1126/scitranslmed.adr2277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 03.12.2025. Verfasst von Sang-Hun Kim und 25 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA. Hauptthemen laut MEDLINE: Macrophage Migration-Inhibitory Factors, Signal Transduction, Alveolar Epithelial Cells, Antigens, Differentiation, B-Lymphocyte. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: NHLBI NIH HHS, NIA NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
Aberrant proteostasis in alveolar type 2 epithelial cells (AEC2s) contributes to idiopathic pulmonary fibrosis (IPF), but the role of the ubiquitin-proteasome system (UPS) is unclear. Here, we show that UPS disruption in AEC2s amplifies profibrotic signaling to macrophages through macrophage migration inhibitory factor (MIF) family proteins in several models. Modeling UPS disruption with an AEC2-specific cullin 3 ( Cul3 ) deletion produced spontaneous fibrosis in a physiological aging mouse model and exacerbated fibrosis in the bleomycin-induced lung injury model. This was accompanied by expansion of transitional epithelial states and increased MIF and MIF-2 in lung tissue and bronchoalveolar lavage fluid (BALF) in the model. Global or conditional AEC2-specific deletions of Mif or Mif-2 attenuated fibrosis in the bleomycin-treated mouse model, as did conditional deletions of Cd74 , the cognate receptor for MIF and MIF-2, in C-X3-C motif chemokine receptor 1 ( Cx3cr1 )–expressing and platelet factor 4 ( Pf4 )–expressing cells. Pharmacological inhibition of MIF attenuated fibrosis in bleomycin-treated and transforming growth factor–β1 ( TGFB1 ) transgenic mouse models and in ex vivo human precision-cut lung slices treated with fibrotic cocktail. In study participants with IPF, BALF MIF was elevated compared with that in study participants without IPF. In participants with IPF, BALF MIF greater than 4000 picograms per milliliter was associated with increased mortality compared with participants with IPF with lower MIF. Together, these findings define a UPS-sensitive epithelial-macrophage signaling connection and identify MIF-CD74 cross-talk as a potential therapeutic target in fibrotic lung disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
- Department of Respiratory Medicine, MHH Hannover Medical School/DZL BREATH, Hannover 30625, Germany.
- Division of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT 06520, USA.
- Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, CO 80206, USA.
- Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
- VA Connecticut Healthcare System, West Haven, CT 06516, USA.
ORCID-Profile: Sang-Hun Kim, Jessica Nouws, Jannik Ruwisch, Gavitt A Woodard, Johad Khoury, Huanxing Sun, Edward P Manning, Min-Jong Kang, Emanuela M Bruscia, Huanhuan Wei, Yuening Zhang, Timur O Yarovinsky, John Hwa, William J Zacharias, Jennifer Ingram, Chun Geun Lee, Jack A Elias, Naftali Kaminski, Elizabeth F Redente, Antje Prasse, Richard Bucala, Maor Sauler
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
- NIAMS NIH HHS
- National Institutes of Health
- Greenfield Foundation
- Gabriel and Alma Elias Research Fund
- U.S. Department of Defense
- G Harold and Leila Y. Mathers Foundation
Zitieren
APA
Kim, S. H., Nouws, J., Ruwisch, J., Woodard, G. A., Cooley, J., Khoury, J., Sun, H., Doherty, E., Piecychna, M., Manning, E. P., Kang, M. J., Bruscia, E. M., Wei, H., Zhang, Y., Yarovinsky, T. O., Hwa, J., Zacharias, W. J., Ingram, J., Lee, C. G., …, & Sauler, M. (2025). Dysregulated alveolar type 2 epithelial cell proteostasis promotes fibrogenic macrophage migration inhibitory factor–CD74 signaling. Science Translational Medicine, 17(827). https://doi.org/10.1126/scitranslmed.adr2277
Vancouver
Kim SH, Nouws J, Ruwisch J, Woodard GA, Cooley J, Khoury J, et al. Dysregulated alveolar type 2 epithelial cell proteostasis promotes fibrogenic macrophage migration inhibitory factor–CD74 signaling. Science Translational Medicine. 2025;17(827). doi:10.1126/scitranslmed.adr2277
BibTeX
@article{Kim2025,
author = {Kim, Sang-Hun and Nouws, Jessica and Ruwisch, Jannik and Woodard, Gavitt A and Cooley, Joseph and Khoury, Johad and Sun, Huanxing and Doherty, Edward and Piecychna, Marta and Manning, Edward P and Kang, Min-Jong and Bruscia, Emanuela M and Wei, Huanhuan and Zhang, Yuening and Yarovinsky, Timur O and Hwa, John and Zacharias, William J and Ingram, Jennifer and Lee, Chun Geun and Elias, Jack A and Kaminski, Naftali and Redente, Elizabeth F and Herzog, Erica L and Prasse, Antje and Bucala, Richard and Sauler, Maor},
title = {Dysregulated alveolar type 2 epithelial cell proteostasis promotes fibrogenic macrophage migration inhibitory factor–CD74 signaling},
journal = {Science Translational Medicine},
year = {2025},
volume = {17},
number = {827},
doi = {10.1126/scitranslmed.adr2277}
}
EUVIMED